基于整合策略的基准,青冈舒陶药丸缓解与年龄相关的记忆衰退的潜在机制
Guiyun Pan1,2, Lijuan Chai3, Rui Chen3
1Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Pharmaceutical biology
|December 25, 2023
概括
青冈舒陶万 (QGSTW) 在老年相关记忆衰退 (AAMI) 的小鼠模型中改善记忆. 研究发现,QGSTW增强了对认知功能至关重要的cAMP信号通路.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 传统中国医药 传统中国医药
背景情况:
- 与年龄相关的记忆力下降 (AAMI) 是一个越来越令人担忧的问题.
- 青冈舒陶万 (QGSTW) 是一种用于AAMI的传统中医药,但其机制尚不清楚.
研究的目的:
- 阐明QGSTW在治疗AAMI中的潜在机制.
- 确定受QGSTW影响的分子标和途径.
主要方法:
- 网络药理学和分子对接被用来预测目标.
- 使用d-银糖建立了AAMI的小鼠模型.
- 用ELISA,免疫光染色和西式涂抹来验证目标和途径.
主要成果:
- 网络药理学确定了cAMP信号通路作为一个关键目标,其中AKT1,FOS,GRIN2B和GRIN1作为核心蛋白质.
- 治疗QGSTW显著改善了小鼠的记忆性能.
- QGSTW增加了cAMP水平,并提高了cAMP通路中的关键蛋白质的调节,包括PKA,CREB,c-Fos,GluN1,GluA1,CaMKII-α和SYN.
结论:
- 通过调节cAMP信号通路,QGSTW可以改善AAMI.
- 这项研究为AAMI提供了QGSTW治疗机制的新见解.
- 这些发现为开发基于中国传统医学的治疗记忆衰退提供了基础.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Role of Neurotransmitters in Memory
565
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
565
Cognitive Development During Adulthood
114
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
114
Aging
54
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
54
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492


